Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Sotera Health (NASDAQ: SHC) announced that company management will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 1:30 p.m. ET / 10:30 a.m. PT.
Company representatives will also hold investor meetings during the conference. A live webcast and accompanying materials will be posted on the company's Investor Relations website, and a replay will be available within 48 hours and remain archived on the site.
Positive
- None.
Negative
- None.
News Market Reaction – SHC
In the Jan 7 session, SHC gained 0.37%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Nov 06 | Secondary offering | Negative | -2.1% | Large sponsor-led secondary sale without proceeds to the company. |
| Nov 04 | Earnings results | Positive | -1.1% | Strong Q3 2025 results and raised EBITDA outlook. |
| Oct 21 | Earnings date notice | Neutral | +0.8% | Announcement of Q3 2025 release date and conference call details. |
| Sep 03 | Secondary offering | Negative | -3.0% | 20M-share secondary sale by Warburg Pincus and GTCR affiliates. |
| Aug 08 | Earnings results | Positive | +24.5% | Strong Q2 2025 growth and raised full-year outlook. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Stock generally aligned with negative secondary-offering headlines, while reactions to strong earnings/news have been mixed, including one notable upside spike.
Over the last six months, SHC has balanced secondary offerings and improving fundamentals. Two large secondary offerings by Warburg Pincus and GTCR in September and November 2025 saw modest share-price declines. In contrast, strong Q2 and Q3 2025 results with raised outlooks on Aug 08 and Nov 04 produced a large positive move once and a small decline once, showing uneven responses to earnings strength. Today’s J.P. Morgan conference appearance fits the pattern of investor-outreach events similar to the Q3 earnings call setup.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CLEVELAND, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time. Company representatives will also participate in investor meetings during the conference.
A live webcast of the presentation, along with accompanying materials, will be available on the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay will be available within 48 hours following the presentation and will remain archived on the Company's website.
About Sotera Health:
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
Updates on matters relevant to investors are available in the Investor Relations section of our website at Investor Relations | Sotera Health. Developments related to Ethylene Oxide are available at Ethylene Oxide | Sotera Health.
INVESTOR RELATIONS CONTACTS:
Jason Peterson
Vice President, Investor Relations
IR@soterahealth.com
MEDIA CONTACT:
Kristin Gibbs
Chief Marketing Officer
kgibbs@soterahealth.com
Source: Sotera Health Company
